Aprea Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.69

+0.07 (+10.51%)

As of Feb 8, 2:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +5,126.1% upside

Low Target $23.45

Average Target $36.06

High Target $38.88

Current Price $0.69

Current
$0.69

Target
$36.06

$23.45 $36.06 avg $38.88

Scenario Analysis

Bear Case

$23.45

3,298.6%

Low target

Base Case

$36.06

+5,126.1%

Avg target

Bull Case

$38.88

+5,534.8%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$39.64

-98.3% from high

52-Week Low

$23.21

+-97.0% from low

Target vs 52W High

$36.06

-9.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%